Rare, mild gastrointestinal discomfort may occur in sensitive individuals
Report it rather than accepting it, because it usually means a medication review is due
Common clinical scenarios for J3490 include newly approved injectable agents awaiting CMS code assignment, compounded injectable medications, and drugs used off-label that fall outside existing code descriptors
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
[10] [13] Early in the research process one of the scientists, who was conducting experiments on himself with an early tool compound, melanotan II, injected himself with twice the dose he intended to and got an eight-hour erection, along with nausea and vomiting
Nothing in the published data licenses treating this molecule as a finished, approved medicine